+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Percutaneous radiofrequency ablation guided by contrast-enhanced ultrasound in treatment of metastatic hepatocellular carcinoma after liver transplantation



Percutaneous radiofrequency ablation guided by contrast-enhanced ultrasound in treatment of metastatic hepatocellular carcinoma after liver transplantation



Asian Pacific Journal of Cancer Prevention 13(8): 3709-3712



This study evaluated the advantages and applications of contrast-enhanced ultrasound (CEUS)-supported percutaneous radiofrequency ablation (RFA) in the treatment of metastatic hepatocellular carcinoma after liver transplantation, based on clinical details. CEUS-supported percutaneous RFA was adopted to treat 12 patients with hepatic metastatic carcinomas after liver transplantation. The diameters of the metastatic carcinomas varied from 1 cm to 5 cm, and the foci were discovered after 3 months to 12 months. Each focus was diagnosed and localised by CEUS for RFA once or twice. Curative effects were evaluated by CEUS or contrast-enhanced CT after the treatment. The re-examination results at 2 weeks post-treatment showed that the foci of 11 patients were ablated completely, whereas one patient with the largest focus required retreatment by RFA because of a partial residue. No local recurrence was found one month later in the re-examination. CEUS-supported percutaneous RFA in the treatment of hepatic metastatic carcinoma after liver transplantation has the advantages of accurate localisation, good efficacy, easy operation, and minimal invasion without any complications. Therefore, it can be recommended as the preferred therapy for hepatic metastatic carcinoma after liver transplantation.

(PDF emailed within 1 workday: $29.90)

Accession: 054922415

Download citation: RISBibTeXText

PMID: 23098459


Related references

Contrast-enhanced ultrasound-guided radiofrequency ablation in inconspicuous hepatocellular carcinoma on B-mode ultrasound. Turkish Journal of Gastroenterology 28(6): 446-452, 2017

Role of contrast enhanced ultrasound in radiofrequency ablation of metastatic liver carcinoma. Chinese Journal of Cancer Research 24(1): 44-51, 2013

Percutaneous radiofrequency ablation guided by contrast-enhanced harmonic sonography with artificial pleural effusion for hepatocellular carcinoma in the hepatic dome. Ajr. American Journal of Roentgenology 182(5): 1224-1226, 2004

Laparoscopic ultrasound-guided radiofrequency ablation as a bridge to liver transplantation for hepatocellular carcinoma: preliminary results. Transplantation Proceedings 42(4): 1179-1181, 2010

The role of contrast-enhanced ultrasound in planning treatment protocols for hepatocellular carcinoma before radiofrequency ablation. Clinical Radiology 62(8): 752-760, 2007

Use of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma. European Journal of Radiology 81(10): 2746-2753, 2013

Ultrasound-guided percutaneous thermal ablation of hepatocellular carcinoma using microwave and radiofrequency ablation. Clinical Radiology 59(1): 53-61, 2003

Contrast-enhanced US-guided radiofrequency ablation of hepatocellular carcinoma. Journal of Vascular and Interventional Radiology 24(8): 1235-1240, 2014

Percutaneous ultrasound-guided radiofrequency ablation (RFA) using saline-perfused (wet) needle electrodes for the treatment of hepatocellular carcinoma--long term experience. Ultraschall in der Medizin 28(6): 604-611, 2007

Application value of real-time three-dimensional contrast-enhanced ultrasound for morphological assessing of hepatocellular carcinoma before radiofrequency ablation treatment. Zhonghua Zhong Liu Za Zhi 40(3): 217-221, 2018

Percutaneous sonographically guided saline-enhanced radiofrequency ablation of hepatocellular carcinoma. Ajr. American Journal of Roentgenology 181(2): 479-484, 2003

Combined transarterial chemoembolization and radiofrequency ablation for small treatment-naïve hepatocellular carcinoma infeasible for ultrasound-guided radiofrequency ablation: long-term outcomes. Acta Radiologica 59(7): 773-781, 2017

Long-term survival of hepatocellular carcinoma after percutaneous radiofrequency ablation guided by ultrasound. World Journal of Surgical Oncology 15(1): 122, 2018

Laparoscopic and percutaneous ultrasound guided radiofrequency ablation for hepatocellular carcinoma: a preliminary study. Taehan Kan Hakhoe Chi 8(2): 209-217, 2002

Comparison of the effectiveness and safety of ultrasound- and CT-guided percutaneous radiofrequency ablation of non-operation hepatocellular carcinoma. Pathology Oncology Research 21(3): 637-642, 2016